Literature DB >> 16414971

Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

L Smeeth1, C Cook, A J Hall.   

Abstract

OBJECTIVE: To investigate time trends, geographical variation, and seasonality in the incidence of diagnosis of polymyalgia rheumatica (PMR) and temporal arteritis (TA) in the United Kingdom.
METHODS: Analysis of computerised medical records from UK general practices. Participants were registered with a practice contributing to the General Practice Research Database during the period 1990-2001. The main outcome measures were rates of diagnosis by year, age, sex, geographical region, and calendar month.
RESULTS: 15 013 people had a first diagnosis of PMR and 3928 a first diagnosis of TA during 17 830 028 person-years of observation. The age adjusted incidence rate of PMR was 8.4/10 000 person-years (95% CI 8.3 to 8.6), rising from 6.9/10 000 person-years in 1990 to 9.3/10 000 in 2001. The age adjusted incidence rate of TA was 2.2/10 000 person-years (95% CI 2.1 to 2.3) with no increase observed. Both PMR and TA were more common in the south than in the north of the UK, and both were more commonly diagnosed in the summer months.
CONCLUSIONS: The explanation for the findings is unclear. Variations in diagnostic practice and accuracy are likely to have contributed in part to the patterns seen. However, the findings are also likely to reflect, at least in part, variations in the incidence of disease. The striking geographical pattern may be partly attributable to a risk factor which is more prevalent in the south and east of the United Kingdom.

Entities:  

Mesh:

Year:  2006        PMID: 16414971      PMCID: PMC1798240          DOI: 10.1136/ard.2005.046912

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  31 in total

1.  The UK General Practice Research Database.

Authors:  T Walley; A Mantgani
Journal:  Lancet       Date:  1997-10-11       Impact factor: 79.321

2.  THE AETIOLOGY, PATHOLOGY AND COURSE OF GIANT-CELL ARTERITIS. THE POSSIBLE ROLE OF LIGHT SENSITIVITY.

Authors:  P D KINMONT; D I MCCALLUM
Journal:  Br J Dermatol       Date:  1965-04       Impact factor: 9.302

Review 3.  Genetic and environmental factors in polymyalgia rheumatica.

Authors:  M A Cimmino
Journal:  Ann Rheum Dis       Date:  1997-10       Impact factor: 19.103

4.  Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.

Authors:  M A González-Gay; C Garcia-Porrua; M J Rivas; P Rodriguez-Ledo; J Llorca
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

5.  The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations.

Authors:  V Petursdottir; H Johansson; E Nordborg; C Nordborg
Journal:  Rheumatology (Oxford)       Date:  1999-12       Impact factor: 7.580

6.  Long-term follow-up of polymyalgia rheumatica: evidence for synovitis.

Authors:  L A Healey
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

7.  Lack of association between infection and onset of polymyalgia rheumatica.

Authors:  J Narváez; M T Clavaguera; J M Nolla-Solé; J Valverde-Garcia; D Roig-Escofet
Journal:  J Rheumatol       Date:  2000-04       Impact factor: 4.666

8.  The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population.

Authors:  C Nordborg; H Johansson; V Petursdottir; E Nordborg
Journal:  Rheumatology (Oxford)       Date:  2003-04       Impact factor: 7.580

9.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

10.  Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA.

Authors:  Michele F Doran; Cynthia S Crowson; W Michael O'Fallon; Gene G Hunder; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2002-08       Impact factor: 4.666

View more
  74 in total

1.  Diagnosis and management of polymyalgia rheumatica.

Authors:  Toby Helliwell; Samantha L Hider; Kevin Barraclough; Bhaskar Dasgupta; Christian D Mallen
Journal:  Br J Gen Pract       Date:  2012-05       Impact factor: 5.386

2.  Diagnosis and management of giant cell arteritis.

Authors:  Kevin Barraclough; Christian D Mallen; Toby Helliwell; Samantha L Hider; Bhaskar Dasgupta
Journal:  Br J Gen Pract       Date:  2012-06       Impact factor: 5.386

3.  Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.

Authors:  M Yates; Y K Loke; R A Watts; A J MacGregor
Journal:  Clin Rheumatol       Date:  2013-09-12       Impact factor: 2.980

4.  Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study.

Authors:  Rossana Scrivo; Maria Chiara Gerardi; Iolanda Rutigliano; Paola Sessa; Daniele Mipatrini; Gaetana Maria Grazia Stricchiola; Elena Pacella; Alessio Altobelli; Chiara Castellani; Cristiano Alessandri; Fulvia Ceccarelli; Manuela Di Franco; Roberta Priori; Valeria Riccieri; Antonio Sili Scavalli; Francesca Romana Spinelli; Giuseppe La Torre; Fabrizio Conti; Guido Valesini
Journal:  Clin Rheumatol       Date:  2018-05-07       Impact factor: 2.980

5.  Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.

Authors:  Jianhua Wu; Adam Keeley; Christian Mallen; Ann W Morgan; Mar Pujades-Rodriguez
Journal:  CMAJ       Date:  2019-06-24       Impact factor: 8.262

6.  Epidemiology of giant cell arteritis in an Arab population: a 22-year study.

Authors:  Neil R Miller
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

Review 7.  The geo-epidemiology of temporal (giant cell) arteritis.

Authors:  Jennifer L Lee; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 8.  Polymyalgia rheumatica.

Authors:  Clement J Michet; Eric L Matteson
Journal:  BMJ       Date:  2008-04-05

Review 9.  Diagnosis and treatment of giant cell arteritis.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Michele Bertoni; Carlo Salvarani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 10.  Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies.

Authors:  Patompong Ungprasert; Matthew J Koster; Kenneth J Warrington; Eric L Matteson
Journal:  Rheumatol Int       Date:  2016-08-30       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.